Major Win: Delhi High Court Greenlights Dr. Reddy's for Export-Only Weight-Loss Drug Production

Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market

Ozempic 2.0: Is the Next-Gen Weight Loss Wonder Drug Really Here to Change Everything?

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Great Surge: Emcure Pharma Bets Big on the Future of Weight Loss

The Hollywood Slimdown: Brooks Nader's Honest Confession and the Price of Perfection

The Weight of Expectation: Hims & Hers Eyes a Major Leap into the GLP-1 Arena

The Game Changer? America's FDA Just Gave the Nod to an Oral Weight Loss Drug, But What's the Catch?

Beyond the Syringe: Can a New Pill Finally Offer a Gentler Path in the Battle Against Obesity?

Viking Therapeutics Nears Major Milestone for Game-Changing Oral Obesity Pill

Ozempic's Arrival: Decoding India's Next Big Bet in Weight Management and Diabetes Care

Ozempic Arrives in India: A New Dawn for Type 2 Diabetes Management and Weight Loss

Chrissy Teigen's Candid Revelation: Ozempic, the Unexpected Lifeline from Deep Depression

Orforglipron: The Oral Weight-Loss Revolution – Promise or Peril?

The Unseen Challenge: Why So Many Are Halting Their Semaglutide Weight Loss Journey